Nancy J Hutson Phase Bio Pharmaceuticals Inc (PHAS) insider trading activity

PHAS Quotes by TradingView

Nancy J Hutson is Director of PhaseBio Pharmaceuticals Inc. Currently has a direct ownership of 37,510 shares of PHAS, which is worth approximately $0. The most recent transaction as insider was on May 19, 2023, when has been sold 3,750 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 37.5K
0% 3M change
0% 12M change
Total Value Held $0

Nancy J Hutson Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 19 2023
BUY
Exercise of conversion of derivative security
-
3,750 Added 9.09%
37,510 Common Stock
Nov 08 2021
BUY
Exercise of conversion of derivative security
$23,310 $3.15 p/Share
7,400 Added 17.98%
33,760 Common Stock
Nov 05 2021
BUY
Exercise of conversion of derivative security
$71,436 $2.71 p/Share
26,360 Added 50.0%
26,360 Common Stock

Also insider at

BCRX
BIOCRYST PHARMACEUTICALS INC Healthcare
Director
CLSD
Clearside Biomedical, Inc. Healthcare
ENDP
Endo International plc Healthcare
Director
NJH

Nancy J Hutson

Director
Stonington, CT

Track Institutional and Insider Activities on PHAS

Follow PhaseBio Pharmaceuticals Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PHAS shares.

Notify only if

Insider Trading

Get notified when an Phase Bio Pharmaceuticals Inc insider buys or sells PHAS shares.

Notify only if

News

Receive news related to PhaseBio Pharmaceuticals Inc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PHAS